Lyell Immunopharma (LYEL) Other Operating Expenses (2020 - 2026)
Lyell Immunopharma (LYEL) posted Other Operating Expenses of $1.9 million for Q1 2026, up 26.65% sequentially from $1.5 million in Q4 2025, and up 1493.28% YoY from $119000.0 in Q1 2025.
Lyell Immunopharma (LYEL) Other Operating Expenses (2020 - 2026) Analysis & Trends
Lyell Immunopharma has reported Other Operating Expenses for 7 years, with the latest figure at $1.9 million in Q1 2026.
- Quarterly Other Operating Expenses rose 1493.28% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 67.75% YoY) and the FY2025 annual result came in at $2.1 million, down 35.18% from the prior year.
- Other Operating Expenses improved to $1.9 million in Q1 2026 per LYEL's latest filing, from $1.5 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $1.9 million in Q1 2026 and troughed at -$1.1 million in Q2 2025.
- A 5-year average of $876117.6 and a median of $1.1 million in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2025 and 2026: Other Operating Expenses slumped 208.81% in 2025, then surged 1493.28% in 2026.
- Over 5 years, Other Operating Expenses stood at $1.2 million in 2022, then sank by 47.02% to $641000.0 in 2023, then fell by 19.97% to $513000.0 in 2024, then surged by 191.81% to $1.5 million in 2025, then climbed by 26.65% to $1.9 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $1.9 million, $1.5 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lyell Immunopharma | 326.39 Mn | 326.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.76 Mn |
| Mar 31, 2026 | 1.90 Mn |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | 119,000.00 |
| Dec 31, 2024 | 513,000.00 |
| Sep 30, 2024 | 730,000.00 |
| Jun 30, 2024 | 976,000.00 |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 641,000.00 |
| Sep 30, 2023 | 292,000.00 |
| Jun 30, 2023 | 569,000.00 |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | 1.21 Mn |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | 1.17 Mn |
| Mar 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 798,000.00 |
| Sep 30, 2021 | 758,000.00 |